Φορτώνει......
Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: integrated results from the phase 3 PIONEER trials
BACKGROUND: Hidradenitis suppurativa (HS) is a chronic skin disease characterized by inflammatory lesions that flare unpredictably. The impact of weekly adalimumab (ADAew) on HS flare is not well‐characterized. OBJECTIVE: To evaluate the impact of disease flare on health‐related quality of life (HRQ...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Eur Acad Dermatol Venereol |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7318582/ https://ncbi.nlm.nih.gov/pubmed/31630445 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdv.16023 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|